2015-06-09 22:22:06 UTC

2015 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference


Dec. 10–12, 2015


The Hilton Orlando
6001 Destination Parkway
Orlando, FL 32819


Endorsed by the AGA Institute

The Crohn's & Colitis Foundation of America (CCFA) and Imedex have collaborated in the development of this meeting to meet the educational needs of all health-care professionals who treat and manage patients with inflammatory bowel diseases. This conference is for health-care professionals and researchers who study and manage patients with inflammatory bowel diseases. The conference consist of four agenda tracks (clinical, basic science, pediatric or nursing) alongside special events, receptions, poster presentations, symposia, and more.

Who Should Take this Course

This activity is designed for gastroenterologists, hospitalists, internal medicine specialists and other health-care professionals (physicians-in-training, nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD.


Member Type Early Discounted Regular
Physicians $424 $524 $649
PhD & PharmD $324 $424 $524
NP/PA/Nurses/Residents/Students $175 $200 $225

To Register

You may register online or by calling Imedex at 800-233-0957 (international attendees please call 678-242-0906). Registration confirmations will be issued before the meeting.


Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.

Contact Imedex at 800-233-0957 (international attendees please call 678-242-0906 or visit imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full).

Registration Fee Inclusions:

Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.

Exhibitor registration fees do not include admittance to the scientific sessions.


For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than Nov. 19, 2015. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. Refunds are not available after Nov. 19, 2015.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.


Clinical Track
Upon successful completion of the clinical track, participants will be better able to:

  • Identify novel evidence-based therapeutics and contemporary treatment options, including the best combinations and sequence of agents for IBD patients in different disease settings.
  • Analyze controversial issues in the multidisciplinary management of pediatric and adult IBD to formulate optimal therapeutic algorithms, with considerations for special patient populations and benefits and risks of treatment options.
  • Identify current surgical options for patients with IBD and plan appropriate post-operative therapeutic management.
  • Recognize primary indications to facilitate endoscopic diagnosis, prognosis and management of IBD.

Basic Science Track
Upon successful completion of the basic science track, participants will be better able to:

  • Interpret the roles of genetic and epigenetic regulation of gene expression in IBD. 
  • Relate the dynamic roles of the microbiome to its effects in modulating inflammatory and other IBD-related disease processes.  
  • Evaluate the immune mechanisms that underlie the pathogenesis of IBD.
  • Overcome challenges in translational research to optimize therapeutic approaches conceptualized in the laboratory and implemented in the clinic.
  • Assess novel models and methodologies that will lead to the elucidation of mechanisms involved in the pathogenesis of IBD.

Pediatrics Track
Upon successful completion of the pediatrics track, participants will be better able to:

  • Determine optimal therapeutic approaches for pediatric patients hospitalized with refractory ulcerative colitis.
  • Recognize and mange psychosocial, behavioral and opioid dependence issues affecting pediatric patients with IBD.
  • Plan optimal use of immunomodulators and biologics for the treatment of pediatric IBD in order to mitigate therapeutic complications.
  • Evaluate “step up” versus “top down” strategies for the management of Crohn’s disease in pediatric patients with growth failure.
  • Identify, diagnosis and manage fistulizing pediatric Crohn’s disease.

Nursing Track
Upon successful completion of the nursing track, participants will be better able to:

  • Evaluate principles of quality improvement to better understand methodologies and tools available to enhance quality of care for patients with IBD.

Traveling? Recommended Accommodations

The Hilton Orlando
6001 Destination Parkway
Orlando, FL 32819
Tel.: 407-313-4300 
Toll Free: 888-488-3509
Fax: 407-313-4301 

For the convenience of attendees, a room block with a limited number of rooms has been reserved at the discounted group rate of $189 single/double occupancy, plus tax, currently at 12.5 percent. This limited number of discounted rooms will be available until Oct. 30, 2015, or after the room block has been filled (whichever comes first). Reservations received after Oct. 30, 2015, or after the room block has been filled, are subject to availability and prevailing hotel rates.

To reserve your room you may contact The Hilton Orlando at 407-313-4300 or through the booking website. To receive the group rate, callers must identify themselves as being with the Advances in IBD 2015 group. Reservation requests received after Oct. 30, 2015, may not be guaranteed the group rate.


If you are bringing a group of five or more people, you must go through Imedex for housing. Please contact Teresa Lovich at t.lovich@imedex.com or 214-679-8736.

About the Instructors

Richard P. MacDermott, MD, and Stephen B. Hanauer, MD 

Contact Information

For questions concerning registration, abstract submissions, obtaining CME certificates or certificates of attendance, to request an invitation letter, or for general inquiries, contact:

Imedex Customer Service
Tel: 678-242-0906; 800-233-0957
Fax: 678-242-0920 
Email: meetings@imedex.com

Conference Organizer

11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009
Tel.: 770-751-7332
Fax: 770-751-7334
Email: meetings@imedex.com

CME Information

Physicians: Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Imedex®, LLC designates this live educational activity for a maximum 19.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurses: An application will be submitted to the Georgia Nurses Association for approval to award nursing contact hours. The Georgia Nurses Association is an accredited approver by the American Nurses Credentialing Center's Center on Accreditation.

Physician Assistants: AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 18 AMA PRA Category 1 Credits for completing this program.

More on Continuing Education

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

Final days to save on AGA Postgraduate Course

April 10, 2018

Early bird deadline is April 18 – last chance to save $75.

Overview of the Regulatory Framework and FDA’s Guidance for the Development and Approval of Biosimilar and Interchangeable Products in the US

April 3, 2018

In this on-demand webinar, Sue Lim, MD provides an overview of the background, terminology and general requirements for biosimilar and interchangeable product applications.